MMWR Recomm Rep. 1993 Sep 17;42(RR-13):1-15.
These recommendations include information on two vaccines recently licensed for use among infants: Haemophilus b Conjugate Vaccine (PRP-T [ActHIB, OmniHIB]), manufactured by Pasteur Mérieux Vaccins, and TETRAMUNE, manufactured by Lederle Laboratories/Praxis Biologics. This statement also updates recommendations for use of other available Haemophilus b vaccines (PRP-D [ProHIBiT]; HbOC [HibTITER]; and PRP-OMP [PedvaxHIB]) for infants and children.
由巴斯德梅里厄疫苗公司生产的b型流感嗜血杆菌结合疫苗(PRP-T [ActHIB、OmniHIB]),以及由礼来实验室/普 Praxis生物制品公司生产的TETRAMUNE。本声明还更新了关于其他可用的b型流感嗜血杆菌疫苗(PRP-D [ProHIBiT];HbOC [HibTITER];以及PRP-OMP [PedvaxHIB])用于婴幼儿的建议。